Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cancer Patients Suppliers In Europe
66 companies found
based inAhrensburg, GERMANY
The biotechnology company Abviris Deutschland GmbH, based in Ahrensburg, Germany, is a pioneer in HPV serology, developing innovative, next generation, products such as Prevo-Check® for early detection and post-treatment monitoring of HPV-induced ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
based inOslo, NORWAY
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer ...
Recent advances in the field of immuno-oncology have established that mutated antigens (neoantigens), are viable targets of the immune system, potentially specific to each individual cancer patient. This plus many ...
based inLa Jolla, CALIFORNIA (USA)
Avelas is a clinical-stage drug-device company pioneering the field of fluorescence imaging for real-time cancer detection. Avelas is focused on the development and commercialization of pegloprastide (also referred to as “AVB-620”), a novel ...
based inLund, SWEDEN
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly ...
Cancer is caused by changes in a once-normal cell, which accumulates genetic damage and mutations in the cell’s “instruction book”, the DNA, causing the cell to grow and multiply uncontrollably. Today, we know much about the many ...
based inLondon, UNITED KINGDOM
Vision RT provides innovative Surface Guided Radiation Therapy (SGRT) solutions for cancer treatment. Vision RT was founded in 2001 with a mission to develop pioneering technology for Surface Guided Radiation Therapy (SGRT), with the goal of ...
based inLittleton, MASSACHUSETTS (USA)
Mevion Medical Systems exists to deliver on the promise of proton therapy for cancer centers, clinicians and patients worldwide. We invented compact proton therapy and are continuing to transform the industry and patient care with the MEVION S250 ...
based inEttlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...
The TheraBionic P1 produces low levels radiofrequency (RF) electromagnetic fields, which are amplitude-modulated at tumor-specific frequencies. The device is coupled with a spoon-shaped antenna, which is placed in the patient’s mouth, more ...
based inLondon, UNITED KINGDOM
Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the ...
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX ...
based inLund, SWEDEN
Our mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. We do this by providing powerful visualization-based bioinformatics data analysis tools for ...
Qlucore's clinical diagnostics solutions for multi-omics companion and precision diagnostics include AI-powered, disease-specific machine learning based classifier models and are combined with patient-friendly visualizations in a an easy-to-use ...
based inMont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
based inSon, NETHERLANDS
Microsure is a medical device company located in Eindhoven (Netherlands) founded by Eindhoven University of Technology and Maastricht University Medical Center in 2016. Our focus is to improve patient’s lives through developing robot systems for ...
LVA or lymph node reconstruction for various indications. The use of a dedicated robot for microsurgery in treating breast cancer-related lymphedema. Women with breast cancer are often treated with (partial) breast and axillary tissue resection and ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
Lumin Bioinformatics is a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The power of Lumin is in the ability to ...
based inAu, Zurich, SWITZERLAND
Araris Biotech AG is pioneering the development of its novel antibody-drug conjugate (ADC)-linker technology to enable efficient and precise production of ADCs. Its linker platform enables the attachment of any drug payload to ‘off the shelf’ ...
based inGeneva, SWITZERLAND
Abologix is a biopharmaceutical company based in Geneva, Switzerland. The company is a spin out from the laboratories of Prof. Beat Imhof and Thomas Matthes at the University of Geneva and the Geneva University Hospitals. The company is developing ...
Olfactomedin-like protein 3 (Olfml3) creates an angiogenic environment in tumours and is associated with vascular growth factors BMP-4 and PDGF. Olfml3 is overexpressed in some cancers. Blocking Olfml3 with highly specific monoclonal antibodies is ...
based inTampa, FLORIDA (USA)
Inspirata, Inc. helps patients fighting cancer, and the clinicians they trust, make every moment matter. Our comprehensive cancer informatics solutions bring together disparate data throughout the entire cancer care journey to drive informed ...
Digital pathology is more than simple image viewing and evaluation. Dynamyx™ streamlines case management by exploiting advances in image digitization and solution interoperability to ensure the accelerated return of patient ...
based inStockholm, SWEDEN
RaySearch® is advancing cancer treatment through pioneering software. Software has unlimited potential, and it is now the driving force for innovation in oncology. Medical science never stands still and neither does RaySearch. We work in close ...
Save time and reduce the risk of error by automating treatment planning. Advanced plan-generating protocols, scripting, automated breast planning, fallback planning, machine learning and plan explorer are some of the tools available in ...
based inStafford, VIRGINIA (USA)
We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
based inGoettingen, GERMANY
We provide the essential products, technologies and expertise to produce biopharmaceuticals reliably and efficiently. In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all ...
Innovation is at the heart of everything we do. Our proprietary drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
